Rheumatoid Arthritis: Where Are We?

Rheumatoid arthritis (RA) is a chronic autoimmune disease that is characterized by joint pain, swelling, stiffness, and decreased movement of the joints. Over time, the chronic inflammation of RA leads to joint damage, bone erosion, and severe disability. The development of conventional and biological disease modifying antirheumatic drugs (DMARDs) has revolutionized the care of patients with rheumatoid arthritis, leading to better control of disease progression, less joint damage, and improvements in quality of life. With newer targeted DMARD therapies, disease remission may be possible.

Rheumatoid Arthritis EASE: Cutting-Edge CME

Our Rheumatoid Arthritis Ease program is an online CME tool that aims to provide clinicians with strategies to improve the standard of care for patients with RA. Our goals are:

  1. Describe the inflammatory pathways that drive the pathophysiology of rheumatoid arthritis.
  2. Review the mechanism of action of conventional and biologic DMARDs.
  3. Discuss clinical trial data for the efficacy and safety of current and emerging biological DMARD therapies.
  4. Identify best practices for the diagnosis, treatment, and monitoring of rheumatoid arthritis.
  5. Recognize disease-related co-morbid conditions and their associated risks in patients with rheumatoid arthritis.

Thank you for visiting our website. Please explore the links above for cutting-edge information on the present and future treatment of rheumatoid arthritis.